Journal of Psychiatry

Mustafa Qureshi

Publications

• Mini Review
  Ketamine’s Journey from Sedation to Suicide Prevention: A Viewpoint
  Author(s): Saeed Ahmed, Mudasar Hassan, Hema Venigalla, Hema Madhuri Mekala and Mustafa QureshiSaeed Ahmed, Mudasar Hassan, Hema Venigalla, Hema Madhuri Mekala and Mustafa Qureshi
  
  Suicide is the tenth leading cause of death in the United States. According to research in 2016, the suicide rate has increased substantially both in the United States and worldwide. Most people who commit suicide are found to suffer from psychiatric illnesses like depression, schizophrenia, anxiety, bipolar disorder, alcoholism, and posttraumatic stress disorder (PTSD). In the past several studies are conducted to examine which drugs decrease suicidal ideation in mentally ill patients. Selective serotonin reuptake inhibitors (SSRIs) like Prozac (fluoxetine) are believed to decrease suicidal intentions in patients with depressive disorders. Similarly, lithium and clozapine are effective in reducing suicidality in patients with bipolar depression and schizophrenia, respectively. Although these drugs have a demonstrated efficacy to reduce suicidality long-term, there is limited evidence.. View More»
  DOI: 10.4172/2378-5756.1000383

  Abstract PDF